Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide

Condition:   Body Weight Changes Interventions:   Drug: CHF Patients: ER Torsemide 40 mg;   Drug: CHF Patients: Furosemide 40 mg Sponsor:   Sarfez Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - April 26, 2018 Category: Research Source Type: clinical trials